Markets are closed for weekend.

Create an Account

Its Free and always will be!

Sign up or login with your social accounts
Birthday
Day

Glenmark Pharmaceuticals enters exclusive agreement with Cyndea Pharma S.L.

Equity tips:-

                                 

  • A  global  pharmaceutical  company,  announced  today  it  has entered  into  a  development,  license, manufacture  and  commercial  supply  agreement with Cyndea Pharma S.L., granting exclusive rights to use their technology for developing  generic, soft‐gelatin capsule formulations of certain pharmaceutical products.
  • "As many as 70 percent of small molecule pharmaceuticals are difficult for the body to absorb,  which leads to challenges in developing effective oral formulations for these medicines,” said  Robert Matsuk, President, North America, Global API at Glenmark Pharmaceuticals. “Because of  these challenges, the use of soft-gelatin capsules have wide applications to improve absorption  and bioavailability of these medicines. Accessing this formulation and manufacturing technology  with our strategic partner Cyndea will support Glenmark’s continued mission of providing  important and cost‐effective generic medicines to patients."
  • Under this agreement, Glenmark receives exclusive rights to the United States and Canada  markets for these soft‐gelatin formulations in exchange for sharing development costs and  profits from future sales. In addition, the agreement provides for the companies to add further  soft‐gelatin product candidates for development and commercialization, as new branded, soft‐ gelatin, capsule‐based drug products become available in the marketplace. 
  • "Glenmark is an ideal partner to expand our soft‐gelatin technology into much needed therapeutic categories and markets,” said Gonzalo Ballesteros, Managing Director of Cyndea.  “Cyndea has made significant financial investments in both its new Madrid‐based research and development facility and state‐of‐the‐art production facility located in Soria, Spain. Cyndea is a  global, market‐leading supplier of generic, prescription, soft‐gelatin capsules in the world and our  partnership with Glenmark provides expanded access into North America." 

If you want to more information regarding the Stock tips,commodity tipsnifty tips missed call @ 9069102223 or fill form http://24cfin.com/free-trial 

Rate this blog entry:
A Checklist To Make Your Stock Investment More Pro...
Birla Sun Life Mutual Fund launches Investor Educa...
 

Comments

No comments made yet. Be the first to submit a comment
Already Registered? Login Here
Guest
Saturday, 24 August 2019

Captcha Image

Popular Investing Books

Nassim Nicholas Taleb
Robert T. Kiyosaki
Michael W. Covel
Saurabh Mukherjea
Paul B. Farrell
Elaine Henry

Search Blogs

Most Popular Authors

Top 100 Investment Blogs

Reduce your Brokerage by 100%!!

 492 members logged in


Be a Smart & Well Informed Investor!
Join Today its Free.
Register or Login with just one Click using your Social Account